Dynamic variation and reversion in the signature amino acids of H7N9 virus during human infection

Journal of Infectious Diseases

Volumn 218, Issue 4, 2018, Pages 586-594

  Zou, Xiaohui ^a   Guo, Qiang ^b   Zhang, Wei ^c   Chen, Hui ^b   Bai, Wei ^c   Lu, Binghuai ^a   Zhang, Wang ^a   Fan, Yanyan ^a   Liu, Chao ^a   Wang, Yeming ^a   Zhou, Fei ^a   Cao, Bin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c NANCHANG UNIVERSITY   (China)

Author keywords

dynamic variation; E627K; H7N9; R292K

Indexed keywords

METHYLPREDNISOLONE; OSELTAMIVIR; PERAMIVIR; VIRUS SIALIDASE; ANTIVIRUS AGENT; VIRAL PROTEIN; VIRUS RNA;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIATION; GENOTYPE; HUMAN; INFLUENZA A (H7N9); INFLUENZA A VIRUS (H7N9); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REVERTANT; SEQUENCE ANALYSIS; VIRUS GENOME; ADOLESCENT; AGED; GENETICS; HIGH THROUGHPUT SEQUENCING; INFLUENZA; ISOLATION AND PURIFICATION; MISSENSE MUTATION; POINT MUTATION; RESPIRATORY SYSTEM; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MUTATION, MISSENSE; OSELTAMIVIR; POINT MUTATION; POLYMORPHISM, GENETIC; RESPIRATORY SYSTEM; RNA, VIRAL; VIRAL PROTEINS;

EID: 85050794917     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiy217     Document Type: Article

References (26)

1. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368: 1888-97.
2. Zhang Q, Shi J, Deng G, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 2013; 341: 410-4.
3. Ke C, Mok CKP, Zhu W, et al. Human infection with highly pathogenic avian influenza A (H7N9) virus, China. Emerg Infect Dis 2017; 23: 1332-40.
4. Yang L, Zhu W, Li X, et al. Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in Mainland China. J Virol 2017; 91: e01277-17.
5. World Health Organization. Monthly risk assessment summary. http://www. who. int/influenza/human-animal-interface/HAI-Risk-Assessment/en/. Accessed 1 February 2018.
6. Watanabe T, Kiso M, Fukuyama S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 2013; 501: 551-5.
7. Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza A (H7N9) virus. Nature 2013; 499: 500-3.
8. Zhu H, Wang D, Kelvin DJ, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 2013; 341: 183-6.
9. Wang D, Yang L, Gao R, et al. Genetic tuning of the novel avian influenza A (H7N9) virus during interspecies transmission, China, 2013. Euro Surveill 2014; 19.
10. Zhang H, Li X, Guo J, et al. The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus. J Gen Virol 2014; 95: 779-86.
11. Marjuki H, Mishin VP, Chesnokov AP, et al. Neuraminidase mutations conferring resistance to oseltamivir in influenza A (H7N9) viruses. J Virol 2015; 89: 5419-26.
12. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013; 381: 2273-9.
13. Sha J, Chen X, Ren Y, et al. Differences in the epidemiology and virology of mild, severe and fatal human infections with avian influenza A (H7N9) virus. Arch Virol 2016; 161: 1239-59.
14. Seifert D, Beerenwinkel N. Estimating fitness of viral quasispecies from next-generation sequencing data. Curr Top Microbiol Immunol 2016; 392: 181-200.
15. Jonges M, Welkers MR, Jeeninga RE, et al. Emergence of the virulence-associated PB2 E627K substitution in a fatal human case of highly pathogenic avian influenza virus A (H7N7) infection as determined by Illumina ultra-deep sequencing. J Virol 2014; 88: 1694-702.
16. Zou XH, Chen WB, Zhao X, et al. Evaluation of a single-reaction method for whole genome sequencing of influenza A virus using next generation sequencing. Biomed Environ Sci 2016; 29: 41-6.
17. Zhou B, Donnelly ME, Scholes DT, et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and swine origin human influenza A viruses. J Virol 2009; 83: 10309-13.
18. Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7. 0 for bigger datasets. Mol Biol Evol 2016; 33: 1870-4.
19. Wang W, Song Z, Guan W, et al. PCR for detection of oseltamivir resistance mutation in influenza A (H7N9) virus. Emerg Infect Dis 2014; 20: 847-9.
20. Wang D, Yang L, Zhu W, et al. Two outbreak sources of influenza A (H7N9) viruses have been established in China. J Virol 2016; 90: 5561-73.
21. Levin-Reisman I, Ronin I, Gefen O, Braniss I, Shoresh N, Balaban NQ. Antibiotic tolerance facilitates the evolution of resistance. Science 2017; 355: 826-30.
22. Yen HL, Zhou J, Choy KT, et al. The R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A/Shanghai/1/2013 (H7N9) influenza virus in ferrets. J Infect Dis 2014; 210: 1900-8.
23. Mok CK, Lee HH, Lestra M, et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol 2014; 88: 3568-76.
24. Yamayoshi S, Fukuyama S, Yamada S, et al. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Sci Rep 2015; 5: 8039.
25. Zhu W, Li L, Yan Z, et al. Dual E627K and D701N mutations in the PB2 protein of A (H7N9) influenza virus increased its virulence in mammalian models. Sci Rep 2015; 5: 14170.
26. Manz B, de Graaf M, Mogling R, et al. Multiple natural substitutions in avian influenza A virus PB2 facilitate efficient replication in human cells. J Virol 2016; 90: 5928-38.